Childhood, adolescent and young adult non-Hodgkin lymphoma: state of the science

被引：25

作者：

Cairo, Mitchell S. ^{[1
]}

Pinkerton, Ross ^{[2
]}

机构：

[1] New York Med Coll, Dept Pediat Med Pathol Microbiol & Immunol & Cell, Skyline Pavil IN-D12,40 Sunshine Cottage Rd, Valhalla, NY 10595 USA

[2] Childrens Hlth Queensland, Dept Oncol, Brisbane, Qld, Australia

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2016年 / 173卷 / 04期

关键词：

childhood; adolescent; young adult; non-Hodgkin lymphoma; state of science; PERIPHERAL T-CELL; CHILDRENS ONCOLOGY GROUP; ACUTE-LYMPHOBLASTIC-LEUKEMIA; MINIMAL DISSEMINATED DISEASE; EPSTEIN-BARR-VIRUS; NATURAL-KILLER-CELLS; HIGH-DOSE METHOTREXATE; PHASE-III TRIAL; BURKITT-LYMPHOMA; RETROSPECTIVE ANALYSIS;

D O I：

10.1111/bjh.14035

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The 5th International Symposium on Childhood, Adolescent and Young Adult (CAYA) Non-Hodgkin Lymphoma (NHL) was held in Varese, Italy, from 21-25 October 2015. This review represents a summary of the scientific sessions of this international symposium including childhood, adolescent and young adult (AYA) NHL in countries with limited socio-economic resources, AYA NHL, anaplastic large cell lymphoma, post-transplant lymphoproliferative disease, Bcell NHL, lymphoblastic lymphoma, T/natural killer cell NHL and immunological therapies in NHL. Most importantly, the new International Paediatric NHL Staging System (IPNHLSS) and International Paediatric NHL Response Criteria (IPNHLRC) were introduced during the symposium. The symposium brought together a multinational and multi-disciplinary group of clinicians and basic scientists focused in this field of haematological malignancies.

引用

页码：507 / 530

页数：24

共 119 条

[1] Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children's Oncology Group [J].

Abromowitch, Minnie ;

Sposto, Richard ;

Perkins, Sherrie ;

Zwick, David ;

Siegel, Stuart ;

Finlay, Jonathan ;

Cairo, Mitchell S. .

BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (02) :261-267

[2] Advanced Stage Anaplastic Large Cell Lymphoma in Children and Adolescents: Results of ANHL0131, a Randomized Phase III Trial of APO Versus a Modified Regimen With Vinblastine: A Report From the Children's Oncology Group [J].

Alexander, Sarah ;

Kraveka, Jacqueline M. ;

Weitzman, Sheila ;

Lowe, Eric ;

Smith, Lynette ;

Lynch, James C. ;

Chang, Myron ;

Kinney, Marsha C. ;

Perkins, Sherrie L. ;

Laver, Joseph ;

Gross, Thomas G. ;

Weinstein, Howard .

PEDIATRIC BLOOD & CANCER, 2014, 61 (12) :2236-2242

[3] Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study [J].

Amylon, MD ;

Shuster, J ;

Pullen, J ;

Berard, C ;

Link, MP ;

Wharam, M ;

Katz, J ;

Yu, A ;

Laver, J ;

Ravindranath, Y ;

Kurtzberg, J ;

Desai, S ;

Camitta, B ;

Murphy, SB .

LEUKEMIA, 1999, 13 (03) :335-342

[4] Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404) [J].

Asselin, Barbara L. ;

Devidas, Meenakshi ;

Wang, Chenguang ;

Pullen, Jeanette ;

Borowitz, Michael J. ;

Hutchison, Robert ;

Lipshultz, Steven E. ;

Camitta, Bruce M. .

BLOOD, 2011, 118 (04) :874-883

[5] Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients [J].

Babcock, GJ ;

Decker, LL ;

Freeman, RB ;

Thorley-Lawson, DA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (04) :567-576

[6] Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia [J].

Balbach, S. T. ;

Makarova, O. ;

Bonn, B. R. ;

Zimmermann, M. ;

Oschlies, I. ;

Klapper, W. ;

Roessig, C. ;

Burkhardt, B. .

LEUKEMIA, 2016, 30 (04) :970-973

[7] NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia [J].

Bandapalli, Obul R. ;

Zimmermann, Martin ;

Kox, Corinne ;

Stanulla, Martin ;

Schrappe, Martin ;

Ludwig, Wolf-Dieter ;

Koehler, Rolf ;

Muckenthaler, Martina U. ;

Kulozik, Andreas E. .

HAEMATOLOGICA, 2013, 98 (06) :928-936

[8] Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group [J].

Barrington, Sally F. ;

Mikhaeel, N. George ;

Kostakoglu, Lale ;

Meignan, Michel ;

Hutchings, Martin ;

Mueeller, Stefan P. ;

Schwartz, Lawrence H. ;

Zucca, Emanuele ;

Fisher, Richard I. ;

Trotman, Judith ;

Hoekstra, Otto S. ;

Hicks, Rodney J. ;

O'Doherty, Michael J. ;

Hustinx, Roland ;

Biggi, Alberto ;

Cheson, Bruce D. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3048-+

[9]

Barth MJ, 2015, BRIT J HAEMATOL, V171, P27

[10] Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-Cell malignancies: A report from the children's oncology group [J].

Berg, SL ;

Blaney, SM ;

Devidas, M ;

Lampkin, TA ;

Murgo, A ;

Bernstein, M ;

Billett, A ;

Kurtzberg, J ;

Reaman, G ;

Gaynon, P ;

Whitlock, J ;

Krailo, M ;

Harris, MB .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3376-3382

← 1 2 3 4 5 6 7 8 9 10 →